Kim Cormier

Chief Sales And Marketing Officer at RevenueWell

Kim Cormier has a diverse work experience in various leadership roles. Kim currently holds the position of Chief Sales and Marketing Officer at RevenueWell since September 2023. Prior to this, they served as the Chief Sales Officer at the same company from March 2023 to September 2023. Before joining RevenueWell, Kim was the Vice President of Provider Data Management and Payer Sales at symplr from July 2021 to March 2023.

From 2019 to 2021, they worked at HealthcareSource as the Sr. Director, Regional Sales & Solutions Consulting. Kim'sresponsibilities included leading a team of Regional Client Executives and Solutions Consultants to achieve sales targets and provide pre-sales support.

Earlier in their career, Kim held roles such as Sr Director of Solutions Marketing at HealthX from April 2018 to February 2019, Senior Director of Marketing at NantHealth from January 2015 to April 2018, and Director, Strategic Product Innovation and Small Business Sales at Blue Cross & Blue Shield of Rhode Island from July 2009 to December 2014.

Before joining Blue Cross & Blue Shield of Rhode Island, they worked at The Health and Wellness Institute as a Strategic Consultant, National Health Management Consultant, and Account Manager, where they provided consulting services and managed corporate health and wellness programs.

Overall, Kim Cormier has a strong background in sales, marketing, and leadership roles, with a focus on driving revenue and achieving sales targets.

Kim Cormier attended Bridgewater State University where they obtained a Bachelor of Science degree in Physical Education Teaching and Coaching. Before that, they also attended the University of Rhode Island, although the specific degree or field of study is not mentioned.

Links

Previous companies

Blue Cross & Blue Shield of Rhode Island logo
HealthcareSource logo
symplr logo
NantHealth logo

Timeline

  • Chief Sales And Marketing Officer

    September, 2023 - present

  • Chief Sales Officer CSO

    March, 2023